<i>Saccharomyces cerevisiae</i> fungemia after probiotic treatment in an intensive care unit patient

Kara, I.; YILDIRIM, FERİHA; Ozgen, ÖZGE; Erganis, SİDRE; Aydogdu, MÜGE; DİZBAY, MURAT; Gursel, GÜL; KALKANCI, AYŞE

doi:10.1016/j.mycmed.2017.09.003

<i>Saccharomyces cerevisiae</i> fungemia after probiotic treatment in an intensive care unit patient

Kara I., YILDIRIM F., Ozgen Ö., Erganis S., Aydogdu M., DİZBAY M., ...Daha Fazla

JOURNAL DE MYCOLOGIE MEDICALE, sa.1, ss.218-221, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.mycmed.2017.09.003
Dergi Adı: JOURNAL DE MYCOLOGIE MEDICALE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.218-221
Anahtar Kelimeler: Saccharomyces, cerevisiae (boulardii), Fungemia, Probiotic, Intensive care unit, CRITICALLY-ILL, TRANSPLANT RECIPIENTS, BOULARDII, INFECTIONS, SAFETY
Gazi Üniversitesi Adresli: Evet

Özet

Saccharomyces cerevisiae is a common colonizer of the human gastrointestinal system as a benign organism. Enteral supplementation of this yeast as a probiotic product is effective in the treatment of antibiotic associated diarrhae. In rare occasions it can cause invasive infections. We present two fungemia cases in an intensive care unit following probiotic treatment containing S. boulardii. We are warning the safety of probiotic treatment in critically ill patients. (C) 2017 Elsevier Masson SAS. All rights reserved.